• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于表型的个体化神经病理性疼痛治疗:我们做到了吗?

Individualized neuropathic pain therapy based on phenotyping: are we there yet?

机构信息

Division of Neurological Pain Research and Therapy, Department of Neurology, University Hospital Schleswig-Holstein, Kiel, Germany.

出版信息

Pain. 2018 Mar;159(3):569-575. doi: 10.1097/j.pain.0000000000001088.

DOI:10.1097/j.pain.0000000000001088
PMID:29447136
Abstract

Patients with the same neuropathic pain disorder may have completely different sensory signs and symptoms yet receive the same medicinal treatment. New concepts suggest that patient stratification according to their pain mechanisms, reflected in their sensory phenotype, could be promising to implement an individualized therapy in neuropathic pain. Retrospective classification of patients according to their sensory phenotype showed predictive validity and reliability for treatment response in certain subgroups of patients. Recent prospective studies using stratification based on sensory phenotypes confirm this concept. In this article, we review the recent accomplishments towards an individualized pharmacological treatment of neuropathic pain.

摘要

患有相同神经病理性疼痛障碍的患者可能具有完全不同的感觉体征和症状,但却接受相同的药物治疗。新概念表明,根据疼痛机制对患者进行分层,反映在他们的感觉表型上,可能有望在神经病理性疼痛中实施个体化治疗。根据感觉表型对患者进行回顾性分类显示出对某些亚组患者治疗反应的预测性和可靠性。最近使用基于感觉表型的分层进行的前瞻性研究证实了这一概念。在本文中,我们回顾了在实现神经病理性疼痛的个体化药物治疗方面的最新成果。

相似文献

1
Individualized neuropathic pain therapy based on phenotyping: are we there yet?基于表型的个体化神经病理性疼痛治疗:我们做到了吗?
Pain. 2018 Mar;159(3):569-575. doi: 10.1097/j.pain.0000000000001088.
2
Individualized pharmacological treatment of neuropathic pain.个体化药物治疗神经病理性疼痛。
Clin Pharmacol Ther. 2015 Feb;97(2):135-42. doi: 10.1002/cpt.19. Epub 2014 Dec 15.
3
Stratification of neuropathic pain patients: the road to mechanism-based therapy?神经病理性疼痛患者的分层:通往基于机制治疗的道路?
Curr Opin Anaesthesiol. 2018 Oct;31(5):562-568. doi: 10.1097/ACO.0000000000000642.
4
Phenotyping neuropathic pain patients: implications for individual therapy and clinical trials.神经病理性疼痛患者表型分析:对个体化治疗和临床试验的影响。
Curr Opin Support Palliat Care. 2014 Jun;8(2):124-9. doi: 10.1097/SPC.0000000000000045.
5
Subgrouping of patients with neuropathic pain according to pain-related sensory abnormalities: a first step to a stratified treatment approach.根据与疼痛相关的感觉异常对神经病理性疼痛患者进行亚组划分:分层治疗方法的第一步。
Lancet Neurol. 2012 Nov;11(11):999-1005. doi: 10.1016/S1474-4422(12)70189-8.
6
Pathophysiological mechanisms of neuropathic pain: comparison of sensory phenotypes in patients and human surrogate pain models.神经病理性疼痛的病理生理学机制:患者和人类替代疼痛模型的感觉表型比较。
Pain. 2018 Jun;159(6):1090-1102. doi: 10.1097/j.pain.0000000000001190.
7
Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): somatosensory abnormalities in 1236 patients with different neuropathic pain syndromes.定量感觉测试在德国神经病理性疼痛研究网络(DFNS)中的应用:1236 例不同神经病理性疼痛综合征患者的躯体感觉异常。
Pain. 2010 Sep;150(3):439-450. doi: 10.1016/j.pain.2010.05.002.
8
Symptom profiles in the painDETECT Questionnaire in patients with peripheral neuropathic pain stratified according to sensory loss in quantitative sensory testing.根据定量感觉测试中的感觉丧失情况分层的外周神经病理性疼痛患者疼痛DETECT问卷中的症状概况。
Pain. 2016 Aug;157(8):1810-1818. doi: 10.1097/j.pain.0000000000000588.
9
Test-retest and interobserver reliability of quantitative sensory testing according to the protocol of the German Research Network on Neuropathic Pain (DFNS): a multi-centre study.根据德国神经性疼痛研究网络(DFNS)的方案进行定量感觉测试的重测信度和观察者间可靠性:一项多中心研究。
Pain. 2011 Mar;152(3):548-556. doi: 10.1016/j.pain.2010.11.013. Epub 2011 Jan 14.
10
Sensory profiles of patients with neuropathic pain based on the neuropathic pain symptoms and signs.基于神经性疼痛症状和体征的神经性疼痛患者的感觉特征。
Pain. 2014 Feb;155(2):367-376. doi: 10.1016/j.pain.2013.10.023. Epub 2013 Oct 25.

引用本文的文献

1
A Computational Framework for Understanding the Impact of Prior Experiences on Pain Perception and Neuropathic Pain.用于理解既往经历对疼痛感知和神经性疼痛影响的计算框架。
PLoS Comput Biol. 2024 Oct 31;20(10):e1012097. doi: 10.1371/journal.pcbi.1012097. eCollection 2024 Oct.
2
8. Herpes zoster and post herpetic neuralgia.8. 带状疱疹及带状疱疹后神经痛。
Pain Pract. 2024 Oct 4;25(1). doi: 10.1111/papr.13423.
3
Painful Diabetic Peripheral Neuropathy: Practical Guidance and Challenges for Clinical Management.疼痛性糖尿病周围神经病变:临床管理的实用指南与挑战
Diabetes Metab Syndr Obes. 2023 Jun 2;16:1595-1612. doi: 10.2147/DMSO.S370050. eCollection 2023.
4
Subgrouping patients with zoster-associated pain according to sensory symptom profiles: A cluster analysis.根据感觉症状特征对带状疱疹相关性疼痛患者进行亚组划分:一项聚类分析。
Front Neurol. 2023 Feb 17;14:1137453. doi: 10.3389/fneur.2023.1137453. eCollection 2023.
5
Optimizing and Accelerating the Development of Precision Pain Treatments for Chronic Pain: IMMPACT Review and Recommendations.优化与加速慢性疼痛精准治疗的发展:IMMPACT综述与建议
J Pain. 2023 Feb;24(2):204-225. doi: 10.1016/j.jpain.2022.08.010. Epub 2022 Oct 2.
6
Developmental mechanisms of CPSP: Clinical observations and translational laboratory evaluations.慢性疼痛综合征的发育机制:临床观察与转化实验室评估
Can J Pain. 2021 Dec 29;6(2):49-60. doi: 10.1080/24740527.2021.1999796. eCollection 2022.
7
Predicting Treatment Response with Sensory Phenotyping in Post-Traumatic Neuropathic Pain.运用感觉表型预测创伤后神经病理性疼痛的治疗反应。
Pain Med. 2022 Sep 30;23(10):1726-1732. doi: 10.1093/pm/pnac045.
8
Brain Imaging Biomarkers for Chronic Pain.慢性疼痛的脑成像生物标志物
Front Neurol. 2022 Jan 3;12:734821. doi: 10.3389/fneur.2021.734821. eCollection 2021.
9
Neuropathic pain and chronic pain as an underestimated interdisciplinary problem.神经病理性疼痛和慢性疼痛作为被低估的跨学科问题。
Int J Occup Med Environ Health. 2022 Jun 8;35(3):249-264. doi: 10.13075/ijomeh.1896.01676. Epub 2022 Jan 4.
10
Combination Therapy for Neuropathic Pain: A Review of Recent Evidence.神经性疼痛的联合治疗:近期证据综述
J Clin Med. 2021 Aug 11;10(16):3533. doi: 10.3390/jcm10163533.